The restricted mean survival time (RMST) analysis technique was introduced in health care research about 25 years ago and ...

ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near-term risk from this therapy due to the higher cost and invasive surgery ...

Results Our data define a ... patient pathway analysis. Conclusions Our findings provide insight into clinical diversity and imply pathogenetic differences between ANA-based subgroups. This supports ...

The speed of medicine has changed. Healthcare professionals are no longer waiting for conferences or clinical guidelines to make key decisions. In fast-paced clinical settings, physicians are actively ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically identify ...

The federal government plans to scrape data from a slew of private health-related records for its autism study, ranging from ...

In 2017, the global medicines supply was interrupted when Hurricane Maria hit Puerto Rico, home to more than 500 medical product ... come from a comprehensive analysis with science-backed ...